APA (7th ed.) Citation

Tada, T., Kumada, T., Hiraoka, A., Kariyama, K., Tani, J., Hirooka, M., . . . Kakizaki, S. (2023). New prognostic system based on inflammation and liver function predicts prognosis in patients with advanced unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A validation study. Cancer Medicine, 12(6), 6980. https://doi.org/10.1002/cam4.5495

Chicago Style (17th ed.) Citation

Tada, Toshifumi, et al. "New Prognostic System Based on Inflammation and Liver Function Predicts Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: A Validation Study." Cancer Medicine 12, no. 6 (2023): 6980. https://doi.org/10.1002/cam4.5495.

MLA (9th ed.) Citation

Tada, Toshifumi, et al. "New Prognostic System Based on Inflammation and Liver Function Predicts Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: A Validation Study." Cancer Medicine, vol. 12, no. 6, 2023, p. 6980, https://doi.org/10.1002/cam4.5495.